Adverse events32

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 32

Type	Event	Organ system	Group	Affected	At risk
other	Palmar-plantar erythrodysesthesia syndrome	Skin and subcutaneous tissue disorders	Regorafenib	4	27
other	Respiratory, thoracic and mediastinal disorders - Other	Respiratory, thoracic and mediastinal disorders	Regorafenib	1	27
other	Acute kidney injury	Renal and urinary disorders	Regorafenib	1	27
other	Confusion	Psychiatric disorders	Regorafenib	1	27
other	Dizziness	Nervous system disorders	Regorafenib	1	27
other	Presyncope	Nervous system disorders	Regorafenib	1	27
other	Syncope	Nervous system disorders	Regorafenib	1	27
other	Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Regorafenib	2	27
other	Generalized muscle weakness	Musculoskeletal and connective tissue disorders	Regorafenib	1	27
other	Muscle weakness lower limb	Musculoskeletal and connective tissue disorders	Regorafenib	1	27
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Regorafenib	1	27
other	Anorexia	Metabolism and nutrition disorders	Regorafenib	1	27
other	Dehydration	Metabolism and nutrition disorders	Regorafenib	2	27
other	Alanine aminotransferase increased	Investigations	Regorafenib	1	27
other	Aspartate aminotransferase increased	Investigations	Regorafenib	1	27
other	Blood bilirubin increased	Investigations	Regorafenib	1	27
other	Investigations - Other	Investigations	Regorafenib	1	27
other	Sinus bradycardia	Cardiac disorders	Regorafenib	1	27
other	Abdominal pain	Gastrointestinal disorders	Regorafenib	1	27
other	Gastrointestinal disorders - Other	Gastrointestinal disorders	Regorafenib	1	27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02466009/events

API reference For AI assistants

Adverse events32

Sources 3

Read this list from software.